IVERIC bio (ISEE) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Brazil’s Lula wins historic fourth term, Flavio Bolsonaro refuses to concede
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- Borr Drilling rig sinks off Gabon, one person dead and four missing
- Oil settles lower on peace hopes, Saudi attacks limit losses
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
Iveric Bio Reports First Quarter 2022 Operational Highlights and Financial Results
May 4, 2022 6:32 AM EDT- Zimura® GATHER2 Topline Data Expected in the Third Quarter of this Year-
- GATHER2 Trial Completion at 94% for Year One; Patient Retention Continues to Exceed Expectations with a Target 12-Month Injection Fidelity Rate of Greater than 90%
- U.S. Patent Covering Methods of Treating GA with Zimura Granted by USPTO
- Conference Call and Webcast Today, May 4, 2022, at 8:00 a.m. ET
PARSIPPANY, N.J.--(BUSINESS... More



